Document:

Supply Agreement

 Exhibit 10.1 

 

	**	CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT
REQUEST UNDER 17 C.F.R. SECTIONS 24b-2, 200.80(B)(4) AND 230.406. 

 SUPPLY AGREEMENT 

This Agreement (the “Agreement”) effective as of the
23rd day of June, 2010 (the “Effective Date”) is
by and between Kensey Nash Corporation, a Delaware corporation, (“Seller”) whose principal place of business is 735 Pennsylvania Drive, Exton, PA 19341 and St. Jude Medical, Cardiology Division, Inc. d/b/a St. Jude Medical, Cardiovascular
Division a Delaware corporation, (“Buyer”), whose principal place of business is at 177 East County Road B, St. Paul, MN 55117 . 

WHEREAS, Buyer desires to purchase Products (as described below) from Seller and Seller desires to sell Products to Buyer under the terms and conditions
set forth herein. 
 NOW, THEREFORE, the parties, wishing to be legally bound, agree as follows: 

1. PRODUCTS: 
 Collagen plugs in their
current design configuration and used in currently commercially available Angio-Seal vascular closure devices (the “Collagen Plug”). Such collagen plugs are currently designated as Buyer’s Part Numbers: 

 

	 	22934-000	Collagen plug, Certified 5 hole, 6f STS 

  

	 	22935-000	Rectangular collagen, 8f STS 

  

	 	23378-000	Collagen plug, VIP, 6f plug 

  

	 	23378-001	Collagen plug, VIP, 8f plug 

  

	 	100000973	6f Aus collagen plug, VIP (Australian derived) 

  

	 	100000974	8f Aus collagen plug, VIP (Australian derived) 

and, meeting the specifications (the “Specifications”) set forth in Schedule A, which is attached to and made a part of this Agreement
(collectively, the “Product”). Such Specifications may be changed from time to time only as agreed to in writing by the parties. 
 2.
DURATION: The duration of this Agreement shall be from the Effective Date until December 31, 2012 (“Initial Term”) unless terminated pursuant to the terms of this Agreement or otherwise agreed in writing by the parties. The
Initial Term will be extended for one year (“Renewal Term”) unless a party provides the other party with written notice of termination on or before March 31, 2012, and such extension shall be contingent upon the parties’
agreement on Pricing with negotitation on Pricing being in good faith. Initial Term and Renewal Term may be referred to as “Term” in this Agreement. 

3. CO-EXCLUSIVITY: Subject to the terms of this Agreement Seller will be, along with Buyer and/or Buyer’s affiliate(s), the co-exclusive
supplier of Collagen Plugs during the Term of this Agreement. 

 4. QUANTITIES: 

4.1 Buyer shall purchase from Seller and Seller shall sell to Buyer a minimum of ** units of Collagen Plugs deliverable in calendar year
2011 and a minimum of ** units of Collagen Plugs deliverable in calendar year 2012 (individually “Annual Minimum” or collectively “Annual Minimums”). 

4.2 For Australian derived collagen plugs, Seller is not obligated to supply in excess of ** units per calendar year. Seller is not
obligated to make more than two deliveries of Australian derived collagen per calendar year unless otherwise agreed to in writing. 
 5.
ORDER AND DELIVERY: 
 5.1 Within two business days of signing of this Agreement, Buyer will issue a binding purchase
order for ** units of Collagen Plugs deliverable on dates in 2011 as described in the purchase order (“2011 Initial Purchase Order”). The 2011 Initial Purchase Order satisfies Buyer’s Annual Minimum purchase obligation for 2011.

 5.2 On or before June 30, 2011 Buyer will issue a binding purchase order for its anticipated 2012 annual needs and
deliverable in 2012 (“2012 Initial Purchase Order”). 
 5.3 Should Buyer elect to purchase Collagen Plugs in volumes
exceeding the Annual Minimum, Buyer shall issue a purchase order stating the desired shipment date(s) and the quantity being ordered. Seller shall acknowledge promptly in writing to Buyer each purchase order issued by Buyer and confirm delivery
dates to destinations specified by Buyer; however, delivery dates must not conflict with Seller’s normal manufacturing lead times. Each delivery of Products shall be accompanied by Seller’s Certificate of Conformance as described more
fully in the Specifications for the Products. If any terms and conditions contained in such purchase order or acknowledgment conflict with the terms of this Agreement, the terms and conditions of this Agreement shall apply to the transaction.
Changes in delivery date(s) or quantity specified in a purchase order may be made by Buyer by means of a written amended purchase order, and shall become effective upon written approval by Seller. 

6. ADDITIONAL QUANTITIES: During the term of this Agreement, Seller agrees to supply up to 110% of the 2011 Initial Purchase Order in calendar
year 2011 and 110% of the 2012 Initial Purchase Order in 2012. In the event that Buyer requires quantities of Product exceeding the initial purchase order in 2011 and/or 2012 by greater than ten percent (10%) (“Quantity In Excess of
Initial Purchase Order”) Buyer shall so notify Seller in writing at least ninety (90) days in advance of Buyer’s desired shipping date for such Quantity In Excess of Initial Purchase Order. Seller shall use commercially reasonable
efforts to meet Buyer’s requirements for such Quantity In Excess of Initial Purchase Order, and shall inform Buyer within thirty (30) days of Seller’s receipt of notice whether or not Seller will supply all or a portion of such
requirements. Should Seller be unable to supply Buyer with any Quantity in Excess of Initial Purchase Order, the Buyer may purchase Product from alternative suppliers only to the extent that Seller can not deliver such Quantity in excess of Initial
Purchase Order, and such actions will not be a breach of any co-exclusivity provisions of this Agreement. 
 7. PRICE: The price for
Products (the “Price”) shall be as set forth in Schedule B attached to this Agreement. 

 8. WARRANTY: Subject to the conditions set forth below, Seller warrants that Products shipped
hereunder meets and complies with the Specifications set forth in Schedule A. Other than the foregoing, SELLER MAKES NO WARRANTIES OF MERCHANTABILITY OR OF FITNESS FOR A PARTICULAR PURPOSE EVEN IF THAT PURPOSE IS KNOWN TO SELLER, NOR ANY OTHER
EXPRESS OR IMPLIED WARRANTY. Buyer assumes all risk and liability for results obtained by the use of Products covered by this Agreement, whether used singly or in combination with other products. 

9. INDEMNIFICATION: Subject to the conditions set forth below, Buyer shall fully indemnify Seller, and Seller’s agents, parent, subsidiaries,
affiliates, employees, officers and directors, successors or assigns against all loss and expense (including, without limitation, reasonable attorney’s fees) for injury to or death of any person or loss of or damage to property incurred by
Seller and resulting in any way from Buyer’s use or sale of vascular closure devices, or any act or omission, whether negligent or otherwise, on the part of the Buyer, its agents, employees, subcontractors or assignees, in connection with the
performance of this Agreement except: (a) when such loss and expense are caused by a defect in any Products which were manufactured by Seller, wherein such defect caused such Products to not meet Specifications, and wherein such Product(s) were
a component of a vascular closure device manufactured and sold by Buyer, or an affiliate of Buyer; or (b) when caused solely by the willful misconduct or negligence of Seller. In the event of either exception set forth in (a) or
(b) in the preceding sentence, Seller shall fully indemnify Buyer, and Buyer’s agents, parent, subsidiaries, affiliates, employees, officers and directors, successors or assigns against all loss and expense (including without limitation,
reasonable attorney’s fees). 
 The indemnifying party’s obligations under this Section shall not apply unless: 

 

	 	A.	The indemnified party gives the indemnifying party prompt written notice of claims for which the indemnified party seeks indemnification; 

 

	 	B.	The indemnified party cooperates with the indemnifying party in the defense of such claims at the cost of the indemnifying party; 

 

	 	C.	The indemnifying party has the sole right to defend any such claim in the manner it deems prudent, including retaining counsel of its choice; and

  

	 	D.	The indemnifying party shall have the sole right to settle any such claim provided that in settling any claim the indemnifying party obtains a complete release for the
indemnified party and does not admit fault or liability on behalf of the indemnified party. 

 10. USE OF TRADEMARK: Each
party agrees that it will not, without the other party’s prior written consent, use and/or associate the other party, the other party’s corporate name or any of the other party’s trademarks, either orally or in writing, with any of
the other party’s products, except that Buyer may use Seller’s name and associate Seller with Buyer’s use of Products as is required by federal or state regulation in gaining approval to market or to continue marketing any of
Buyer’s devices or products. 
 11. CLAIMS OF NON-CONFORMITY: Buyer shall provide notice to Seller of any claim of non-conformity to
Specifications arising from Products within one hundred twenty (120) days after the later of the actual or scheduled date of receipt of the shipment containing the specific Products unit that is the subject of the claim (the “Claim
Period”). Except as to claims for indemnification 

 
set forth in Section 9, failure to give notice of claim within the Claim Period, shall constitute a waiver by Buyer of all claims in respect to such Products. No claim of non-conformity to
Specifications shall be allowed after Products has been processed by Buyer in any manner, except that opening the packages and inspecting Products with normal care in handling shall not constitute processing nor disallow such claim. Payment prior to
inspection of Products by Buyer shall not constitute waiver of any rights under this Agreement. In addition, acknowledgement of receipt on packing slips or bills of lading shall not constitute acceptance of Products by Buyer. Products shall not be
returned to Seller without Seller’s prior permission, and then only in the manner and to the destination prescribed by Seller. Seller shall reimburse Buyer for the actual costs of returning any Products returned in accordance with Seller’s
instructions. Upon Seller’s confirmation of non-conformity, Seller will provide Buyer with credit, refund or replacement at Seller’s option for the non-conforming returned Products. In no event shall either party be liable to the other for
special, indirect or consequential damages. 
 12. QUALITY CONTROL: 

12.1 Inspection, Timing. All Products shall meet the Specifications contained in Schedule A, and shall be subjected to quality
control inspections by Seller in accordance with Seller’s quality control standards and system which should be consistent and in conformity with the laws and regulations set forth in Section 17. If Buyer’s quality control inspection
shows that any Products fails to meet the Specifications contained in Schedule A, Buyer shall notify Seller within forty-five (45) days of discovery of the non-conformity. 

12.2 Lot Traceability. Vascular closure devices manufactured and sold by Buyer, or an affiliate of Buyer, shall contain lot
numbers such that collagen components, including Products supplied hereunder, incorporated in such devices can be traced back to the original supplier’s lot number. 

13. DELIVERIES: Deliveries shall be F.O.B. Exton, Pennsylvania, USA via standard freight carrier, using shipper of Buyer. Buyer shall be
responsible for all delivery costs and will be invoiced for such by Seller. Title to and risk of loss in all Products sold hereunder shall pass to Buyer upon loading for shipment at Seller’s plant. 

14. TERMS OF PAYMENT: Buyer will pay to Seller the Invoiced Price net cash thirty (30) days from date of Seller’s invoice. Seller may
impose a late payment service charge of 1.5% per month on invoices not paid when due. All payments shall be in United States currency. 

15. FINANCIAL RESPONSIBILITY: In the event Buyer fails to fulfill the terms of payment, or in case Seller shall have reasonable doubt at any time
as to Buyer’s financial responsibility, Seller may decline to make further deliveries except upon receipt of cash or satisfactory security. 

16. FORCE MAJEURE: No liability shall result from delay in performance, or nonperformance, caused by circumstances beyond the control of the party
affected, including, but not limited to, Act of God, fire, flood, war, Government action, or accident. Quantities so affected may be eliminated from the Agreement without liability, but the Agreement shall remain otherwise unaffected, except that in
the event Seller fails to deliver an amount to Buyer under this Section 16 following a forty-five (45) day cure period, Buyer may source Product itself or through a third party, to the extent of such failure by Seller, without breaching
any exclusivity provisions of this Agreement. If Seller invokes this Section 16, any deliveries of Product subject to this Provision will be credited against the Annual Minimum. Any party claiming the benefit of this Section shall promptly so
notify the other party. 

 17. GOVERNMENT REGULATION/APPROVALS – RESPONSES TO THIRD PARTY COMPLAINTS OR CLAIMS: Buyer shall
be responsible for obtaining all necessary government approvals to market any device incorporating the Products. Seller shall manufacture Products under this Agreement in material compliance with the U.S. Quality System Regulation (QSR) and ISO
13485. Any changes to the Specifications relating to the Products must be agreed to in writing by both parties before such changes are implemented. Seller considers process validation to be a requirement of the QSR; therefore, Buyer shall either
fund such required validations, subject to negotiation with Seller regarding the price and extent of validation, or provide Seller with written confirmation that Buyer will assume all responsibility for validation. Upon terms of confidentiality
acceptable to Seller, Seller agrees to cooperate with Buyer in obtaining any such governmental approvals, including providing required information to the FDA or any other governmental agency requesting the information to the extent such information
is readily available or can be developed at little or no cost to Seller, unless Buyer agrees to fund such information research and preparation. Similarly, Seller agrees to provide reasonable assistance, including information and data, as needed by
Buyer to respond to complaints or claims asserted by third parties regarding devices incorporating the Products. If services or consulting is required to respond to issues raised by a governmental agency or in a complaint or claims asserted by a
third party beyond what is customarily or reasonably provided without charge (“Supplemental Consulting”), Seller will notify Buyer of its intent to charge for Supplemental Consulting with an estimate for anticipated charges. If, after
notice of Seller’s intent to charge, Buyer requests such Supplemental Consulting, Seller will charge at a rate that is discounted by twenty percent (-20%) from its regular consulting rates. 

18. DOCUMENTS INCORPORATED BY REFERENCE: The following documents are hereby incorporated by reference: 

A. Schedule A, entitled “Products Specifications”. 

B. Schedule B, entitled “Pricing”. 

19. ADVERSE EVENTS, COMPLAINTS AND EFFECTS: Buyer will investigate all adverse events, complaints and effects of which Buyer has direct or
indirect knowledge, in regard to any of Buyer’s devices which incorporate Products. Buyer agrees to promptly report to Seller any such events, complaints or effects that may relate to Products. Buyer shall be responsible for all medical device
reporting (MDR), vigilance reporting and/or recalls associated with any devices made or sold by Buyer which incorporate Products. Seller shall be notified in writing about any such reports or recalls that appear to relate to Products. 

20. COMPLIANCE WITH LAW: Each party represents that it is and will remain in material compliance with all applicable federal, state and local
laws, regulations and orders, regarding the manufacture and distribution of Products or product that incorporate Products. 
 21. INDEPENDENT
CONTRACTOR: The employees, methods, equipment and facilities of each party shall at all times be under that party’s exclusive direction and control. Buyer’s relationship to Seller under this Agreement shall be that of an independent
contractor and nothing in this Agreement shall be construed to constitute either party, or any of its employees, an agent, associate, joint venturer or partner of the other party. 

22. NOTICES: All notices required hereunder shall be sent by certified mail return receipt requested, or by telex confirmed by

 
such certified mail, to the party to be notified at its following address or at such other address as shall have been specified in written notice from the party to be notified. If to
“Seller”, addressed to: Kensey Nash Corporation, 735 Pennsylvania Drive, Exton, PA 19341, attention: Joseph W. Kaufmann. If to “Buyer”, addressed to: St. Jude Medical, Cardiology Divison, Inc. d/b/a St. Jude Medical,
Cardiovascular Division 177 East County Road B, St. Paul, MN 55117, attention: Vice President Finance and Supply Chain with a copy to: Vice President and General Counsel, St. Jude Medical, Cardiovascular Division, 177 East County Road B, St. Paul,
MN 55117. 
 23. ASSIGNMENT: This Agreement is not assignable or transferable by one party, in whole or in part, without the prior
written consent of the other party, which consent shall not be unreasonably withheld, provided, however, that Buyer may assign this Agreement without Seller’s consent to an affiliate or a purchaser of all or substantially all of Buyer’s
assets. 
 24. CLAUSE HEADINGS: The headings of clauses contained herein are used for convenience and ease of reference and shall not
limit the scope or intent of the clause. 
 25. ENTIRETY OF AGREEMENT: This Agreement embodies the entire agreement and understanding
between Seller and Buyer regarding the supply of collagen plugs for calendar years 2011 and 2012 and any extension of this Agreement beyond 2011 and 2012. The parties expressly agree that the parties’ Supply Agreement dated June 30, 2005,
as amended, applies to orders for deliveries of collagen plugs in calendar year 2010 (“Prior Agreement”) and that the Prior Agreement will expire and terminate according to its terms on December 31, 2010. No amendment, modification or
release from any provision hereof shall be of any force or effect unless it is in writing, signed by the parties, and specifically refers to this Agreement. 

26. WAIVER: No waiver by either party or any breach of the covenants herein contained to be performed by the other party shall be construed as a
waiver of any succeeding breach of the same or any other covenants or conditions hereof. 
 27. TERMINATION: The Agreement may be
terminated by either party if: 
 27.1 The other party is in material breach of any material term or obligation of this
Agreement and such material breach is not cured within thirty (30) days after receipt of written notice of such material breach from the terminating party, provided however, that if the nature of the breaching party’s obligations are such
that more than thirty (30) days are required for cure, then such party shall not be in default if it shall have commenced performance to cure within the thirty (30) day period and thereafter diligently attempts to complete performance of
cure.; or 
 27.2 The other party is adjudicated insolvent, has a receiver of its assets or property appointed, or files or has
filed against it a petition in bankruptcy and such breach is not cured within sixty (60) days of such event; or 
 27.3 The
other party ceases or threatens to cease to carry on all or any substantial part of its business that is relevant to this Agreement; or 

27.4 The parties’ obligations pursuant to Sections 8, 9, 11, 19, 20, 28, 29 and 30 shall survive termination or expiration of this
Agreement. 
 28. CONFIDENTIALITY: Both parties acknowledge that before and during the Term, both parties may provide or may continue to
provide the other with certain proprietary and confidential information, including, without limitation, prices, data, designs, plans, drawings, technical information, trade secrets, know-how, processes, customer information, complaint analysis and

 
investigation, marketing strategies and competitive information (“Confidential Information”). Each agrees that it will not, during the Term, or after, for any reason, publish or
disclose to any third party, except to the FDA or other competent regulatory agency, without the advance, express written authorization from the other party, any such Confidential Information, nor, except to the extent such Confidential Information
is necessary in performance of this Agreement, will it use such Confidential Information. 
 28.1 Confidential Information does
not include information which (i) is known to the receiving party prior to receipt from the disclosing party; or (ii) is or becomes public knowledge without breach of the disclosing party’s obligation; or (iii) is rightfully
acquired by the disclosing party from a third party without restriction on disclosure or use; or (iv) is publicly disclosed or used following disclosing party’s receipt of written consent for such disclosure or use by an officer of the
other party; or (v) disclosure is compelled by deposition, subpoena or other judicial requirement or governmental action, as evidenced by advice of legal counsel, provided that the receiving party give the disclosing party prompt advanced
written notice of the Confidential Information to be disclosed as far in advance of its disclosure as is reasonably possible, practicable and legally permissible to permit the other party to obtain a protective order or take other responsive action.

 28.2 The requirements of this Section terminate five (5) years after the termination or expiration of this Agreement or
any renewal of this Agreement. Upon termination or expiration of this Agreement, and upon request of the other party, all materials and copies of Confidential Information shall be immediately returned to the other party, except that the receiving
party may retain one archival copy in their respective legal department’s files for purposes of monitoring compliance of this Agreement, and may also retain any required documents or drawings required to be held in the Device History File or
other applicable QSR or regulatory file. 
 29. NO PUBLICITY: Neither Buyer nor Seller will issue any press release with respect to this
Agreement or any related agreements or the transactions contemplated by the parties, or otherwise make any oral or written statements or disclosures with respect to such agreements or transactions or the existence of the parties’ relationship
or discussions, without the prior written consent of the other party, which consent shall not be unreasonably withheld, except to those of such party’s employees and representatives as may need to know such information for purposes of the
transactions contemplated by the parties’ agreements, and except as may be required by applicable law or by obligations pursuant to any listing agreement with or rules of any national securities exchange. In the case of any such required
disclosure, the disclosing party will: (1) provide the other party with written notice of the required disclosure at least forty-eight (48) hours in advance of such disclosure; and (2) limit such disclosure to the minimum required
under the applicable law or obligations. 
 30. NON-SOLICIT/NO-HIRE: During the term of this Agreement and for a period of one
(1) year thereafter, Seller and Buyer will not attempt to solicit nor directly or indirectly hire the other party’s employees or subcontractors that become known to Seller or Buyer through the performance of this Agreement. 

31. CLOSED HERD: Seller shall maintain sufficient records to demonstrate that raw material has met the requirements of a Closed Herd per current
ISO 22442-2 for any such source of raw material where the Products are specified by Buyer to come from a Closed Herd. Specific requirements for sourcing of Products shall be controlled by Specifications and any applicable laws or regulations.

 32. COUNTERPARTS: This Agreement may be executed in counterparts, each of which shall be deemed an
original, but all of which shall constitute one and the same instrument. 
 Accepted: 

 

									
	Kensey Nash Corporation	 		 	 St. Jude Medical, Cardiology Division, Inc.

d/b/a St. Jude Medical, Cardiovascular Division

					
	By:	 	 /s/ Joseph W. Kaufmann
	 		 		 	
	Name:	 	 Joseph W. Kaufmann
	 		 	By:	 	 /s/ Brian Hansen

	Title:	 	 President & CEO
	 		 	Name:	 	 Brian Hansen

	Date:	 	 June 21, 2010
	 		 	Title:	 	 Vice President Finance

		 		 		 	Date:	 	 June 23, 2010

 SCHEDULE A 

PRODUCTS SPECIFICATIONS 

Specifications follow this page. 

** [13 pages redacted] 
  

					
	 	  	KNC	  	SJM
			
	Initials	  	JWK	  	BH
			
	 Date
	  	6/21/10	  	6/23/10

 SCHEDULE B 

PRICING 
 All Collagen
Plug prices in the chart below are effective for orders placed for delivery in calendar years 2011 and 2012 and are for closed herd derived Product, or Australian derived Product. 

** [1 page redacted] 
  

					
	 	  	KNC	  	SJM
			
	Initials	  	JWK	  	BH
			
	 Date
	  	6/21/10	  	6/23/10Fifth Supplemental Indenture, dated as of June 28, 2010

 Exhibit 4.1 

 
  

América Móvil, S.A.B. de C.V., 

as Issuer 

and 

Radiomóvil Dipsa, S.A. de C.V., 

as Guarantor 

to 
 The Bank of
New York Mellon, 
 as Trustee, Security Registrar, Paying Agent and Transfer Agent 

and 
 The Bank of
New York Mellon (Luxembourg) S.A., 
 as Luxembourg Paying Agent and Luxembourg Transfer Agent 

 
  

FIFTH SUPPLEMENTAL INDENTURE 

Dated as of June 28, 2010 
  

 

€1,000,000,000 

3.75% Senior Notes due 2017 
  

 

 TABLE OF CONTENTS 

 

					
	 	  	 	  	Page
	ARTICLE ONE DEFINITIONS	  	2
			
	Section 101.	  	Provisions of the Base Indenture	  	2
	Section 102.	  	Definitions	  	2
		
	ARTICLE TWO GENERAL TERMS AND CONDITIONS OF THE NOTES	  	4
			
	Section 201.	  	Designation, Principal Amount and Interest Rate	  	4
	Section 202.	  	Denominations	  	4
	Section 203.	  	Computation of Interest	  	4
	Section 204.	  	Forms Generally	  	4
	Section 205.	  	Form of Trustee’s Certificate of Authentication	  	14
	Section 206.	  	Registration of Transfer and Exchange	  	15
	Section 207.	  	Maintenance of Office or Agency	  	15
	Section 208.	  	Euro MTF Listing	  	16
	Section 209.	  	Additional Amounts	  	16
		
	ARTICLE THREE MISCELLANEOUS PROVISIONS	  	16
			
	Section 301.	  	Consent to Service; Jurisdiction	  	16
	Section 302.	  	Indemnification of Judgment Currency	  	17
	Section 303.	  	Governing Law; Waiver of Jury Trial	  	17
	Section 304.	  	Separability of Invalid Provisions	  	17
	Section 305.	  	Execution in Counterparts	  	17
	Section 306.	  	Certain Matters	  	18

 FIFTH SUPPLEMENTAL INDENTURE, dated as of June 28, 2010 (this “Fifth Supplemental
Indenture”), among América Móvil, S.A.B. de C.V., a sociedad anónima bursátil de capital variable organized and existing under the laws of the United Mexican States (“Mexico”) (herein called the
“Company”), having its principal office at Lago Alberto 366, Edificio Telcel I, Colonia Anáhuac, Delegación Miguel Hidalgo, 11320, Mexico, D.F., Mexico, Radiomóvil Dipsa, S.A. de C.V., a sociedad anónima de
capital variable organized and existing under the laws of Mexico (herein called the “Guarantor”), having its principal office at Lago Alberto 366, Edificio Telcel II, Colonia Anáhuac, Delegación Miguel Hidalgo, 11320,
Mexico, D.F., Mexico, and The Bank of New York Mellon, a banking corporation duly organized and existing under the laws of the State of New York authorized to conduct a banking business, as Trustee (herein called the “Trustee”), Security
Registrar, Paying Agent and Transfer Agent, and The Bank of New York Mellon (Luxembourg) S.A., as Luxembourg Paying Agent (herein called the “Luxembourg Paying Agent”) and Luxembourg Transfer Agent, to the Indenture, dated as of
September 30, 2009, among the Company, the Guarantor and the Trustee (herein called the “Base Indenture” and, together with this Fifth Supplemental Indenture, herein called the “Indenture”). 

W I T N E S S E T H: 

WHEREAS, Section 301 of the Base Indenture provides for the issuance from time to time thereunder, in series, of debt Securities of
the Company, and Section 901 of the Base Indenture provides for the establishment of the form or terms of Securities issued thereunder through one or more supplemental indentures; 

WHEREAS, the Company desires by this Fifth Supplemental Indenture to create a series of Securities to be issued under the Base Indenture,
as supplemented by this Fifth Supplemental Indenture, and to be known as the Company’s “3.75% Senior Notes due 2017” (the “Notes”), which are to be initially limited in aggregate principal amount as specified in this Fifth
Supplemental Indenture and the terms and provisions of which are to be as specified in this Fifth Supplemental Indenture; 

WHEREAS, the Company has duly authorized the execution and delivery of this Fifth Supplemental Indenture to establish the Notes as a
series of Securities under the Base Indenture and to provide for, among other things, the issuance and form of the Notes and the terms, provisions and conditions thereof, and additional covenants for purposes of the Notes and the Holders thereof;

 WHEREAS, the Guarantor has duly authorized the execution and delivery of this Fifth Supplemental Indenture to provide for the
Guarantees of the Notes; and 
 WHEREAS, all things necessary to make this Fifth Supplemental Indenture a valid agreement of the
Company and the Guarantor, in accordance with its terms, have been done. 
 NOW, THEREFORE, for and in consideration of the
premises and the purchase and acceptance of the Notes by the Holders thereof and for the purpose of setting forth, as provided in the Base Indenture, the form of the Notes and the terms, provisions and conditions thereof, the Company and the
Guarantor covenant and agree with the Trustee and the Luxembourg Paying Agent as follows: 

 ARTICLE ONE 

DEFINITIONS 
 Section
101. Provisions of the Base Indenture. 
 Except insofar as herein otherwise expressly provided, all the definitions,
provisions, terms and conditions of the Base Indenture shall remain in full force and effect. The Base Indenture, as supplemented by this Fifth Supplemental Indenture, is in all respects ratified and confirmed, and the Base Indenture and this Fifth
Supplemental Indenture shall be read, taken and considered as one and the same instrument for all purposes and every Holder of Notes authenticated and delivered under this Fifth Supplemental Indenture shall be bound hereby. Notwithstanding any other
provision of this Section 101 or the Base Indenture or this Fifth Supplemental Indenture to the contrary, to the extent any provisions of this Fifth Supplemental Indenture or any Note issued hereunder shall conflict with any provision of the
Base Indenture, the provisions of this Fifth Supplemental Indenture or the Note, as applicable, shall govern. 
 Section 102.
Definitions. 
 For all purposes of this Fifth Supplemental Indenture and the Notes, except as otherwise expressly
provided or unless the subject matter or context otherwise requires: 
 (a) any reference to an “Article” or a
“Section” refers to an Article or Section, as the case may be, of this Fifth Supplemental Indenture; 
 (b) the words
“herein,” “hereof” and “hereunder” and other words of similar import refer to this Fifth Supplemental Indenture as a whole and not to any particular Article, Section or other subdivision; 

(c) all terms used in this Fifth Supplemental Indenture and not defined herein have the meanings assigned to them in the Base Indenture;

 (d) the term “Securities” as defined in the Base Indenture and as used therein (including in any definition
therein), shall be deemed to include or refer to, as applicable, the Notes; 
 (e) the term “Depositary” as used in
the Indenture shall be deemed to refer, with respect to the Notes, to Clearstream, Luxembourg and Euroclear, until a successor Depositary shall have become Depositary pursuant to the applicable provisions of the Base Indenture, and thereafter
“Depositary” shall mean such successor Depositary; 
 (f) the term “Applicable Procedures of the Depositary”
as used in the Indenture shall be deemed to refer, with respect to the Notes, to the rules and procedures of Clearstream, Luxembourg and Euroclear, to the extent applicable as in effect from time to time; 

(g) all accounting terms not otherwise defined in the Base Indenture or this Fifth Supplemental Indenture have the meanings assigned to
them in accordance with Mexican generally accepted accounting principles and the term “Mexican generally accepted accounting principles” with respect to any computation required or permitted thereunder or hereunder shall mean such
accounting principles as are generally accepted in Mexico at the date of such computation; provided that at any time 
  

 2 

 
the Company shall report its financial information under International Financial Reporting Standards (“IFRS”), such accounting terms shall have the meanings assigned to them in
accordance with IFRS; and 
 (h) the following terms have the meanings given to them in this Section 102(h). 

“Business Day” means each Target System Day. A “Target System Day” is any day on which the Trans-European Automated
Real Time Gross Settlement Express Transfer (TARGET) System (or any successor thereto) is open for business and a day on which commercial banks are open for dealings in euro deposits in the London interbank market. With respect to Notes in
certificated form, the reference to “Business Day” will also mean a day on which banking institutions generally are open for business in the location of each office of a Transfer Agent, but only with respect to a payment or other action to
occur at that office. 
 “Common Depositary” means The Bank of New York Depository (Nominees) Limited, as common
depositary for the Depositary. 
 “euro” means the euro or such other lawful currency of the member states of the
European Monetary Union that have adopted or that will adopt the single currency in accordance with the Treaty Establishing the European Community, as amended by the Treaty on European Union, as at the time of payment shall be legal tender for the
payment of public and private debts. 
 “Global Note” means a Note that evidences all or part of the Notes and is
authenticated and delivered to, and registered in the name of, the Common Depositary for such Notes or a nominee thereof. 

“Government Securities” means (i) direct obligations of a member state of the European Monetary Union that has adopted the
single currency in accordance with the Treaty Establishing the European Community, as amended by the Treaty on European Union (a “Member State”), (ii) obligations the timely payment of the principal of and interest on which is fully
and unconditionally guaranteed by a Member State or the European Central Bank, and (iii) certificates, depositary receipts or other instruments which evidence a direct ownership interest in obligations described in Clause (i) or
(ii) above or in any specific principal or interest payments due in respect thereof. 
 “Interest Payment Date”
means each June 28, commencing on June 28, 2011. 
 “Predecessor Note” means, with respect to any particular
Note, every previous Note evidencing all or a portion of the same debt as that evidenced by such particular Note; and, for the purposes of this definition, any Note authenticated and delivered under Section 305 of the Base Indenture in exchange
for or in lieu of a mutilated, destroyed, lost or stolen Note shall be deemed to evidence the same debt as the mutilated, destroyed, lost or stolen Note. 

“Specified London Office of the Paying Agent” means, initially, the London Branch of The Bank of New York Mellon, located at
One Canada Square, London E14 5AL, United Kingdom. 
  

 3 

 ARTICLE TWO 

GENERAL TERMS AND CONDITIONS OF THE NOTES 

Section 201. Designation, Principal Amount and Interest Rate. 

(a) There is hereby authorized and established a series of Securities designated the “3.75% Senior Notes due 2017,” initially in
an aggregate principal amount of €1,000,000,000 (which amount does not include Notes authenticated and delivered upon registration of transfer of, in exchange for, or in lieu of, other Securities of such series pursuant to Sections 304, 305,
306, 906 or 1205 of the Base Indenture), which amount shall be specified in the Company Order for the authentication and delivery of Notes pursuant to Section 303 of the Base Indenture. The principal of the Notes shall be due and payable at
their Stated Maturity. 
 (b) The Company may, from time to time and without the consent of the Holders, issue additional notes,
with Guarantees of the Guarantor duly annexed thereto or endorsed thereon, on terms and conditions identical to those of the Notes (except for issue date, issue price and the date from which interest shall accrue and, if applicable, first be paid),
which additional notes, together with Guarantees of the Guarantor duly annexed thereto or endorsed thereon, shall increase the aggregate principal amount of, and shall be consolidated and form a single series with, the Notes. 

(c) The Stated Maturity of the Notes shall be June 28, 2017. The Notes shall bear interest at the rate of 3.75% per annum from
June 28, 2010 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, as the case may be, payable annually in arrears on June 28, commencing on June 28, 2011, until the principal thereof is
paid or made available for payment on or prior to the Stated Maturity of the Notes; provided, however, that any amount of interest on any Note which is overdue shall bear interest (to the extent that payment thereof shall be legally
enforceable) at the rate per annum then borne by such Note from the date such amount is due to the day it is paid or made available for payment, and such overdue interest shall be paid as provided in Section 306 of the Base Indenture.

 Section 202. Denominations. 

The Notes shall be issued only in denominations of €50,000 and integral multiples of €1,000 in excess thereof. 

Section 203. Computation of Interest. 

Interest on the Notes shall be computed on the basis of a 365-day year or 366-day year, as applicable, and the actual number of days
elapsed. 
 Section 204. Forms Generally. 

The Notes and the Guarantees annexed thereto or endorsed thereon shall be in substantially the forms set forth in this Section 204,
with such appropriate insertions, omissions, substitutions and other variations as are required or permitted by this Fifth Supplemental Indenture, and may have such letters, numbers or other marks of identification and such legends or endorsements
placed thereon as may be required to comply with the rules of any securities exchange or as may, consistently herewith, be determined by the officers executing such Notes, as evidenced by their execution thereof, with Guarantees duly annexed thereto
or endorsed thereon; provided that if any Notes are issued in 
  

 4 

 
certificated and not global form, such Notes shall be in substantially the form set forth in this Section 204, but shall not contain the legends relating to Global Notes or the
“Schedule of Increases or Decreases in Global Note.” 
 Upon their original issuance, the Notes shall be issued in the
form of one or more Global Notes in definitive, fully registered form, with Guarantees annexed thereto or endorsed thereon, without coupons, substantially in the form set forth in this Section 204. Such Global Notes shall be registered in the
name of the Common Depositary, or its nominee, and deposited with the Common Depositary, duly executed by the Company, with Guarantees duly annexed thereto or endorsed thereon, and authenticated by the Trustee as hereinafter provided. The aggregate
amount of any Global Notes may from time to time be increased or decreased by adjustments made on the records of the Common Depositary. 

(a) Form of Face of Note. 

[INCLUDE IF NOTE IS A GLOBAL NOTE AND THE COMMON DEPOSITARY IS THE BANK OF NEW YORK MELLON DEPOSITORY (NOMINEES) LIMITED, AS COMMON
DEPOSITARY FOR CLEARSTREAM, LUXEMBOURG AND EUROCLEAR—THIS NOTE IS A GLOBAL SECURITY AND IS REGISTERED IN THE NAME OF THE BANK OF NEW YORK MELLON DEPOSITORY (NOMINEES) LIMITED, AS COMMON DEPOSITARY (THE “COMMON DEPOSITARY”) FOR
CLEARSTREAM BANKING, SOCIÉTÉ ANONYME AND EUROCLEAR BANK S.A./N.V. UNLESS AND UNTIL THIS NOTE IS EXCHANGED IN WHOLE OR IN PART FOR NOTES IN DEFINITIVE FORM, THIS NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE COMMON DEPOSITARY OR
ANOTHER DEPOSITARY OR BY THE COMMON DEPOSITARY OR A NOMINEE OF THE COMMON DEPOSITARY TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCESSOR DEPOSITARY.] 

AMÉRICA MÓVIL, S.A.B. DE C.V. 

3.75% Senior Notes due 2017 

ISIN Number: XS0519903743 / Common Code: 051990374 
  

			
	No.	  	                              
                          €1,000,000,000

América Móvil, S.A.B. de C.V. (herein called the “Company,” which term includes any successor Person under the
Indenture hereinafter referred to, a sociedad anónima bursátil de capital variable organized and existing under the laws of the United Mexican States (“Mexico”), for value received, hereby promises to pay to The Bank
of New York Depository (Nominees) Limited, or registered assigns, as common depositary for Clearstream Banking, société anonyme and Euroclear Bank, S.A./N.V., the principal sum of One Billion euro (or such other lawful currency of the
member states of the European Monetary Union that have adopted or that will adopt the single currency in accordance with the Treaty Establishing the European Community, as amended by the Treaty on European Union, as at the time of payment shall be
legal tender for the payment of public and private debts), as revised by the Schedule of Increases and Decreases in Global Note attached hereto on June 28, 2017 (unless earlier redeemed, in which case, on the applicable Redemption Date) and to
pay interest thereon from June 28, 2010 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, as the case may be, annually in arrears on June 28 of each year, commencing on June 28, 2011
at the rate of 3.75% per annum, until the principal hereof is paid or made available for payment; provided that any amount of interest on this Note which is overdue shall bear interest (to the extent that payment thereof shall be legally
enforceable) at the rate per annum then borne by this Note from the date such amount is due to but not including the day it is paid or made available for payment, and such overdue interest shall be paid as provided in Section 306 of the Base
Indenture. 
  

 5 

 Interest on the Notes shall be calculated on the basis of a 365-day year and 366-day year,
as applicable, and the actual number of days elapsed from and including the last Interest Payment Date (or, with respect to interest payable on the first Interest Payment Date, from the issue date of this Note) to but excluding the Interest Payment
Date on which the interest payment falls due. 
 The interest so payable, and punctually paid or duly provided for, on any
Interest Payment Date shall, as provided in the Indenture, be paid to the Person in whose name this Note (or one or more Predecessor Notes) is registered at the close of business on the Regular Record Date for such interest, which shall be the
June 15 (whether or not a Business Day) next preceding such Interest Payment Date. Any such interest not so punctually paid or duly provided for shall forthwith cease to be payable to the Holder on the relevant Regular Record Date and may
either be paid to the Person in whose name this Note (or one or more Predecessor Notes) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be
given to Holders of this Note not less than 10 days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange on which this Note may be listed, and upon
such notice as may be required by such exchange, all as more fully provided in the Indenture. 
 Payment of the principal of and
interest on this Note shall be made at the office of the Trustee or agency of the Company in the Borough of Manhattan, The City of New York, New York and at the Specified London Office of the Paying Agent and, if and for so long as the Notes are
admitted to listing on the Official List of the Luxembourg Stock Exchange and trading on the Euro MTF, at the office of the Luxembourg Paying Agent, in each case maintained for such purpose and at any other office or agency maintained by the Company
for such purpose, in euro (or such other lawful currency of the member states of the European Monetary Union that have adopted or that will adopt the single currency in accordance with the Treaty Establishing the European Community, as amended by
the Treaty on European Union, as at the time of payment shall be legal tender for the payment of public and private debts) against surrender of this Note in the case of any payment due at the Maturity of the principal thereof (other than any payment
of interest that first becomes payable on a day other than an Interest Payment Date); provided, however, that at the option of the Company payment of interest may be made by check mailed to the address of the Person entitled thereto as such
address shall appear in the Security Register. [If the Note is a Global Note, then insert — Notwithstanding the foregoing, payment of any amount payable in respect of a Global Note shall be made in accordance with the Applicable
Procedures of the Depositary.] 
 Reference is hereby made to the further provisions of this Note set forth on the reverse
hereof, which further provisions shall for all purposes have the same effect as if set forth at this place. 
 Unless the
certificate of authentication hereon has been executed by the Trustee referred to on the reverse hereof by manual signature, this Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 

 

 6 

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed. 

Dated: 
  

			
	AMÉRICA MÓVIL, S.A.B. DE C.V.
		
	 By:
	 	 
		 	Name:
		 	Title:
		
	 By:
	 	 
		 	Name:
		 	Title:

 (b) Form of Reverse of
Note. 
 This Note is one of a duly authorized issue of securities of the Company (herein collectively called the
“Notes”), issued under an Indenture, dated as of September 30, 2009 (herein called the “Base Indenture”), among the Company, Radiomóvil Dipsa, S.A. de C.V., a sociedad anónima de capital variable
organized and existing under the laws of Mexico (herein called the “Guarantor,” which term includes any successor Person under the Indenture), The Bank of New York Mellon, as Trustee (herein called the “Trustee,” which term
includes any successor trustee under the Indenture), Security Registrar, Paying Agent and Transfer Agent, as supplemented by the Fifth Supplemental Indenture dated as of June 28, 2010 (herein called the “Fifth Supplemental Indenture”
and, together with the Base Indenture, the “Indenture”), among the Company, the Guarantor, the Trustee and The Bank of New York Mellon (Luxembourg) S.A., as Luxembourg Paying Agent (herein called the “Luxembourg Paying Agent”)
and Luxembourg Transfer Agent, and reference is hereby made to the Indenture for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Guarantor, the Trustee and the Holders of the Notes
and of the terms upon which the Notes are, and are to be, authenticated and delivered. The terms, conditions and provisions of this Note are those stated in the Indenture (including those made a part of the Indenture by reference to the Trust
Indenture Act) and those set forth in this Note. This Note is one of the series designated on the face hereof. 
 Additional
notes on terms and conditions identical to those of this Note (except for issue date, issue price and the date from which interest shall accrue and, if applicable, first be paid) may be issued by the Company without the consent of the Holders of the
Notes. The amount evidenced by such additional Notes shall increase the aggregate principal amount of, and shall be consolidated and form a single series with, the Notes, in which case the Schedule of Increases and Decreases in Global Note attached
hereto will be correspondingly adjusted. 
 In any case where any Interest Payment Date, Redemption Date or Stated Maturity of
any Note shall not be a Business Day, then (notwithstanding any other provision of the Indenture or of the Notes) payment of principal and premium, if any, or interest need not be made on such date, but may be made on the next succeeding Business
Day with the same force and effect as if made on the Interest Payment Date, Redemption Date or at the Stated Maturity, as the case may be; provided that no interest shall accrue for the period from and after such Interest Payment Date, Redemption
Date or Stated Maturity, as the case may be. 
 In the event of redemption of this Note in part only, a new Note or Notes of
this series and of like tenor for the unredeemed portion hereof shall be issued in the name of the Holder hereof upon the cancellation hereof. 
  

 7 

 If an Event of Default with respect to Notes shall occur and be continuing, the principal of
all of the Notes may be declared due and payable in the manner and with the effect provided in the Indenture. 
 All payments of
principal, premium, if any, and interest in respect of the Notes shall be made after withholding or deduction for any present or future taxes, duties, assessments or governmental charges of whatever nature imposed, levied, collected, withheld or
assessed by or on behalf of Mexico or any authority therein or thereof having power to tax (“Mexican Taxes”). In the event of any withholding or deduction for any Mexican Taxes, the Company shall pay such additional amounts
(“Additional Amounts”) as will result in receipt by the Holders of Notes on the respective due dates of such amounts as would have been received by them had no such withholding or deduction (including for any Mexican Taxes payable in
respect of Additional Amounts) been required, except that no such Additional Amounts shall be payable with respect to any payment on a Note to the extent: 

(i) that any such taxes, duties, assessments or other governmental charges would not have been imposed but for (A) a
connection between the Holder and Mexico other than the ownership or holding of such Note and the mere receipt of payments with respect to such Note or (B) failure by the Holder or any other Person to comply with any certification,
identification or other reporting requirement concerning the nationality, residence, identity or connection with Mexico of the Holder or any beneficial owner of such Note if compliance is required by law, regulation or by an applicable income tax
treaty to which Mexico is a party, as a precondition to exemption from, or reduction in the rate of, the tax, assessment or other governmental charge and we have given the Holders at least 30 days’ notice prior to the first payment date with
respect to which such certification, identification or reporting requirement is required to the effect that Holders will be required to provide such information and identification; 

(ii) of any such taxes, duties, assessments or other governmental charges with respect to such Note presented for payment
more than 15 days after the date on which such payment became due and payable or the date on which payment thereof is duly provided for and notice thereof given to Holders, whichever occurs later, except to the extent that the Holder of such Note
would have been entitled to such Additional Amounts on presenting such Note for payment on any date during such 15-day period; 

(iii) of estate, inheritance, gift or other similar taxes, assessments or other governmental charge imposed with respect
to such Note; 
 (iv) of any tax, duty, assessment or other governmental charge payable otherwise than by
deduction or withholding from payments on such Note; and 
 (v) of any payment on such Note to a Holder who is a
fiduciary or partnership or a person other than the sole beneficial owner of any such payment, to the extent that a beneficiary or settlor with respect to such fiduciary, a member of such a partnership or the beneficial owner of such payment would
not have been entitled to the Additional Amounts had such beneficiary, settlor, member or beneficial owner been the Holder of such Note. 

For purposes of the provisions described in Clause (i) above, the term “Holder” of any Note means the direct nominee of
any beneficial owner of such Note, which holds such beneficial owner’s interest in such Note. Notwithstanding the foregoing, the limitations on the Company’s obligation to pay Additional Amounts set forth in Clause (i)(B) above shall not
apply if (a) the provision of information, documentation or other evidence described in such Clause (i)(B) would be materially 

 

 8 

 
more onerous, in form, in procedure or in the substance of information disclosed, to a Holder or beneficial owner of a Note (taking into account any relevant differences between U.S. and Mexican
law, regulation or administrative practice) than comparable information or other reporting requirements imposed under U.S. tax law (including the United States - Mexico Income Tax Treaty), regulations (including proposed regulations) and
administrative practice or (b) Rule I.3.22.8 is in effect, unless the provision of the information, documentation or other evidence described in such Clause (i)(B) is expressly required by statute, regulation, rule or administrative practice in
order to apply Rule I.3.22.8 and the Company cannot obtain such information, documentation or other evidence on its own through reasonable diligence and the Company otherwise would meet the requirements for application of Rule I.3.22.8. In addition,
such Clause (i)(B) shall not be construed to require that a non-Mexican pension or retirement fund or a non-Mexican financial institution or any other Person register with the Ministry of Finance and Public Credit for the purpose of establishing
eligibility for an exemption from or reduction of Mexican withholding tax. 
 The Company shall provide the Trustee with the
constancia or other relevant documentation, if any (which may consist of certified copies of such documentation), satisfactory to the Trustee evidencing the payment of Mexican Taxes in respect of which the Company has paid any Additional
Amounts. Copies of such documentation shall be made available to the Holders of the Notes or any Paying Agent, as applicable, upon request therefor. 

The Company shall pay all stamp, issue, registration, documentary or other similar duties, if any, which may be imposed by Mexico or any
other governmental entity or political subdivision therein or thereof, or any taxing authority of or in any of the foregoing, with respect to the Indenture or the issuance of the Notes. 

For the avoidance of doubt, no Additional Amounts will be payable to any Holder with respect to any non-Mexican Taxes, including any
taxes withheld on a Note pursuant to the European Union Savings Directive or any law implementing or complying with, or introduced in order to conform to the European Union Savings Directive. 

All references herein and in the Indenture or the Guarantees, to principal, premium, if any, or interest or any other amount payable in
respect of any Note shall be deemed to include all Additional Amounts, if any, payable in respect of such principal, premium, interest or other amount payable, unless the context otherwise requires, and express mention of the payment of Additional
Amounts in any provision hereof shall not be construed as excluding reference to Additional Amounts in those provisions hereof where such express mention is not made. 

In the event that Additional Amounts actually paid with respect to the Notes pursuant to the preceding paragraphs are based on rates of
deduction or withholding of withholding taxes in excess of the appropriate rate applicable to the Holder of such Notes, and, as a result thereof such Holder is entitled to make claim for a refund or credit of such excess from the authority imposing
such withholding tax, then such Holder shall, by accepting such Notes, be deemed to have assigned and transferred all right, title, and interest to any such claim for a refund or credit of such excess to the Company. However, by making such
assignment, the Holder makes no representation or warranty that the Company will be entitled to receive such claim for a refund or credit and incurs no other obligation with respect thereto. 

All references herein and in the Indenture and the Guarantees to principal in respect of any Note shall be deemed to mean and include any
Redemption Price payable in respect of such Note pursuant to any redemption right hereunder (and all such references to the Stated Maturity of the principal in respect of any Note shall be deemed to mean and include the Redemption Date with respect
to any such 
  

 9 

 
Redemption Price), and all references to principal, premium, interest or Additional Amounts shall be deemed to mean and include any amount payable in respect hereof pursuant to Section 1009
of the Base Indenture. 
 The Company may, at its option, redeem the Notes upon not less than 30 nor more than 60 days’
notice, at any time and, only in the case of clause (ii) below, from time to time: 
 (i) in whole but not
in part at a Redemption Price equal to the sum of (A) 100% of the outstanding principal amount of the Notes, (B) accrued and unpaid interest on the principal amount of the Notes to but not including the Redemption Date and (C) any
Additional Amounts which would otherwise be payable thereon up to but not including the Redemption Date, solely if, as a result of any amendment to, or change in, the laws (or any rules or regulations thereunder) of Mexico or any political
subdivision or taxing authority thereof or therein affecting taxation or any amendment to or change in an official interpretation or application of such laws, rules or regulations, which amendment to or change of such laws, rules or regulations
becomes effective on or after June 28, 2010, the Company would be obligated, after making reasonable endeavors to avoid such requirement, to pay Additional Amounts in excess of the Additional Amounts that the Company would be obligated to pay
if payments made on the Notes were subject to withholding or deduction of Mexican Taxes at the rate of 4.9%; provided, however, that (1) no notice of redemption pursuant to this clause (i) may be given earlier than 90 days prior to the
earliest date on which the Company would be obligated to pay such Additional Amounts if a payment on the Notes were then due and (2) at the time such notice of redemption is given, the Company’s obligation to pay such Additional Amounts
remains in effect; and 
 (ii) in whole or in part, at a Redemption Price equal to the greater of (1) 100%
of the outstanding principal amount of the Notes being redeemed and (2) the sum of the present values of the remaining scheduled payments of principal and interest thereon (exclusive of interest accrued to the Redemption Date) discounted to the
Redemption Date on an annual basis (calculated using a 365-day year or a 366-day year, as applicable, and the actual number of days elapsed) at the Bund Rate plus 35 basis points, plus, in the case of (1) and (2), accrued and unpaid interest on
the principal amount of such Notes to but not including the Redemption Date. 
 For purposes of clause (ii) above, the
following terms shall have the specified meanings: 
 “Bund Rate” means, as of any Redemption Date, the rate per annum
equal to the yield to maturity as of such Redemption Date of the Comparable German Bund Issue, assuming a price for the Comparable German Bund Issue (expressed as a percentage of its principal amount) equal to the Comparable German Bund Price for
such Redemption Date. 
 “Comparable German Bund Issue” means the German Bundesanleihe security selected by any
Reference German Bund Dealer as having a fixed maturity most nearly equal to the remaining term of the Notes to be redeemed and that would be utilized at the time of selection and in accordance with customary financial practice, in pricing new
issues of euro-denominated corporate debt securities in a principal amount approximately equal to the then outstanding principal amount of the Notes to be redeemed and of a maturity most nearly equal to the remaining term of the Notes to be
redeemed; provided, however, that, if the remaining term of the Notes to be redeemed is not equal to the fixed maturity of the German Bundesanleihe security selected by such Reference German Bund Dealer, the Bund Rate shall be determined by
linear interpolation (calculated to the nearest one-twelfth of a year) from the yields of German 
  

 10 

 
Bundesanleihe securities for which such yields are given, except that if the remaining term of the Notes to be redeemed is less than one year, a fixed maturity of one year shall be used.

 “Comparable German Bund Price” means, with respect to any Redemption Date, the average of all Reference German Bund
Dealer Quotations for such date (which, in any event, must include at least two such quotations), after excluding the highest and lowest such Reference German Bund Dealer Quotations, or if the Trustee obtains fewer than four such Reference German
Bund Dealer Quotations, the average of all such quotations. 
 “Reference German Bund Dealer” means each of Deutsche
Bank AG, London Branch, HSBC Bank plc and BNP Paribas, or their affiliates, which are dealers of German Bundesanleihe securities and one other leading dealer of German Bundesanleihe securities reasonably designated by the Company; provided,
however, that if any of the foregoing shall cease to be a dealer of German Bundesanleihe securities, the Company will substitute therefor another dealer of German Bundesanleihe securities. 

“Reference German Bund Dealer Quotation” means, with respect to each Reference German Bund Dealer and any Redemption Date, the
average, as determined by the Trustee, of the bid and asked prices for the Comparable German Bund Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Trustee by such Reference German Bund Dealer at 3:30
p.m. (Frankfurt, Germany time) on the third business day preceding such Redemption Date. 
 The Indenture permits, with certain
exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the Guarantor, on the one hand, and the rights of the Holders of the Notes, on the other hand, at any time by the Company,
the Guarantor and the Trustee with the consent of the Holders of a majority in principal amount of the Notes at the time Outstanding. The Indenture also contains provisions (1) permitting the Holders of a majority in principal amount of the
Notes at the time Outstanding, on behalf of the Holders of all Notes, to waive compliance by the Company with certain provisions of the Indenture and (2) permitting the Holders of a majority in principal amount of the Notes at the time
Outstanding, on behalf of the Holders of all Notes, to waive certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Note shall be conclusive and binding upon such Holder and upon all future
Holders of this Note and of any Note issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Note. 

As provided in and subject to the provisions of the Indenture, the Holder of this Note shall not have the right to institute any
proceeding with respect to the Indenture or for the appointment of a receiver or trustee, or for any other remedy thereunder, unless such Holder shall have previously given the Trustee written notice of a continuing Event of Default with respect to
the Notes, the Holders of not less than 25% in principal amount of the Notes at the time Outstanding shall have made written request to the Trustee to institute proceedings in respect of such Event of Default as Trustee and offered the Trustee
indemnity reasonably satisfactory to it, and the Trustee shall not have received from the Holders of a majority in principal amount of Notes at the time Outstanding a direction inconsistent with such request, and shall have failed to institute any
such proceeding, for 60 days after receipt of such notice, request and offer of indemnity. The foregoing shall not apply to any suit instituted by the Holder of this Note for the enforcement of any payment of principal hereof or premium, if any,
and/or interest hereon on or after the respective due dates expressed herein. 
 No reference herein to the Indenture and no
provision of this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and premium, if any, and interest on this Note at the times, place and rate, and in the coin
or currency, herein prescribed. 
  

 11 

 As provided in the Indenture, and subject to certain limitations therein set forth
(including, without limitation, the restrictions on transfer under Section 204 of the Fifth Supplemental Indenture and Sections 202 and 304 of the Base Indenture), the transfer of this Note is registrable in the Security Register, upon
surrender of this Note for registration of transfer at the office of the Trustee or agency of the Company in any place where the principal of and premium, if any, and interest on this Note are payable, duly endorsed by, or accompanied by a written
instrument of transfer in form satisfactory to the Company, the Guarantor and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Notes of this series and of like
tenor, of authorized denominations and for the same aggregate principal amount, shall be issued to the designated transferee or transferees. 

The Notes are issuable only in registered form without coupons in denominations of €50,000 and integral multiples of €1,000 in
excess thereof. As provided in the Indenture, and subject to certain limitations therein set forth, Notes are exchangeable for a like aggregate principal amount of Notes of like tenor of a different authorized denomination, as requested by the
Holder surrendering the same. 
 No service charge shall be made for any such registration of transfer or exchange, but the
Company or the Trustee may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 

Prior to due presentment of this Note for registration of transfer, the Company, the Guarantor, the Trustee and any agent of the Company,
the Guarantor or of the Trustee may treat the Person in whose name this Note is registered as the owner hereof for all purposes, whether or not this Note is overdue, and neither the Company, the Guarantor, the Trustee nor any such agent shall be
affected by notice to the contrary. 
 [If the Note is a Global Note, then insert — This Note is a Global Note and
is subject to the provisions of the Indenture relating to Global Notes, including the limitations in Section 204 of the Fifth Supplemental Indenture and Sections 202 and 304 of the Base Indenture on transfers and exchanges of Global Notes.]

 This Note, the Guarantees and the Indenture shall be governed by, and construed in accordance with, the law of the State of
New York. 
 All terms used in this Note which are defined in the Indenture shall have the meanings assigned to them in the
Indenture. 
  
  

ABBREVIATIONS 

The following abbreviations, when used in the inscription of the face of this Note, shall be construed as though they were written out in
full according to applicable laws or regulations: 
  

					
	TEN COM -	 	as tenants in common	  	UNIF GIFT MIN ACT—______________
		 		  	                             
                       (Cust)
			
	TEN ENT -	 	as tenants by the entireties	  	Custodian _____________ under Uniform
		 		  	                          
(Minor)
			
	JT TEN -	 	as joint tenants with right of survivorship and not as tenants in common	  	Gifts to Minors Act ________________
		 	  	                             
               (State)

 Additional
abbreviations may also be used 
 though not in the above list. 

 
  

 

 12 

 SCHEDULE OF INCREASES OR DECREASES IN GLOBAL NOTE 

The following increases or decreases in this Global Note have been made: 

 

									
	 Date of
Transfer or
Exchange
	 	 Amount of decrease
in Principal
Amount of
this
Global Note
	 	 Amount of increase
in Principal
Amount of
this
Global Note
	 	 Principal Amount
of this Global Note
following
such
decrease or increase
	 	 Signature of
authorized
signatory of Trustee
or
Note Custodian

		 		 		 		 	
		 		 		 		 	
		 		 		 		 	
		 		 		 		 	
		 		 		 		 	
		 		 		 		 	

 (c) Form of Guarantee. 

Radiomóvil Dipsa, S.A. de C.V., a sociedad anónima de capital variable organized and existing under the laws of
Mexico (the “Guarantor”), hereby fully and unconditionally guarantees (such guarantee being referred to herein as the “Guarantee”), in accordance with the terms of the Indenture, dated as of September 30, 2009 (herein called
the “Base Indenture”), among América Móvil, S.A.B. de C.V., the Guarantor and The Bank of New York Mellon, as Trustee (the “Trustee”), Security Registrar, Paying Agent and Transfer Agent, as supplemented by the
Fifth Supplemental Indenture, dated as of June 28, 2010 (the “Fifth Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), among the Company, the Guarantor, the Trustee and the Bank of New York
Mellon (Luxembourg) S.A., as Luxembourg Paying Agent and Luxembourg Transfer Agent, the full and punctual payment when due, whether at maturity, upon redemption, by acceleration or otherwise, of the principal of, premium, if any, and interest on,
and any other amounts due under the Notes and all other obligations of the Company under the Indenture including, without limitation, if any such payment is subject to withholding for or on account of any taxes, duties, assessments or other
governmental charges imposed with respect thereto by a Mexican taxing authority, payments of additional amounts to the Holders of the Note to which this Guarantee is annexed so that the net amount received by such Holder equals the amount that would
have been received absent such withholding, subject to the limitations provided in the Note to which this Guarantee is annexed and Section 1009 of the Base Indenture. Capitalized terms used but not defined herein shall have the respective
meanings given to them in the Indenture. 
 The obligations of the Guarantor to the Holders and to the Trustee pursuant to this
Guarantee and the Indenture shall be limited to the maximum amount as shall, after giving effect to all other liabilities (fixed and contingent) of the Guarantor, result in the obligations of the Guarantor under the Guarantees not constituting a
fraudulent conveyance or fraudulent transfer under applicable law. 
  

 13 

 The obligations of the Guarantor to the Holders and to the Trustee pursuant to this
Guarantee and the Indenture are expressly set forth, to the extent and in the manner provided, in Article Eleven of the Base Indenture and reference is hereby made to the Indenture for the precise terms of the Guarantee therein made. 

This Guarantee shall not be valid or obligatory for any purpose until the certificate of authentication on the Note to which this
Guarantee is annexed shall have been executed by the Trustee under the Indenture by the manual signature of one of its authorized signatories. 

This Guarantee shall be governed by, and construed in accordance with, the law of the State of New York. 

This Guarantee is subject to release upon the terms set forth in the Indenture. 

IN WITNESS WHEREOF, the Guarantor has caused this Guarantee to be duly executed. 

 

			
	RADIOMÓVIL DIPSA, S.A. de C.V.,
		
	By:	 	 
		 	Name:
		 	Title:
		
	By:	 	 
		 	Name:
		 	Title:

 Section 205. Form of Trustee’s
Certificate of Authentication 
 The Trustee’s certificate of authentication shall be in substantially the following
form: 
 This is one of the Notes referred to in the within-mentioned Indenture. 

Dated: 
  

			
	 THE BANK OF NEW YORK MELLON,

        as Trustee

		
	 By:
	 	 
		 	Authorized Officer

  

 14 

 Section 206. Registration of Transfer and Exchange 

(a) Section 304(2) of the Base Indenture is hereby amended and restated with respect to the Notes as follows: 

“(2) Notwithstanding any other provision in this Indenture or the Notes, no Global Note may be exchanged in whole or
in part for Notes registered, and no transfer of a Global Note in whole or in part may be registered, in the name of any Person other than the Depositary or a nominee thereof unless (A) the Depositary has notified the Company that it is
unwilling or unable to continue as Depositary for such Global Note and a successor Depositary is not appointed within 90 days, (B) there shall have occurred and be continuing an Event of Default with respect to such Global Note or (C) a
request for certificates has been made by the Company upon 60 days’ prior written notice given to the Trustee in accordance with the Applicable Procedures of the Depositary and a copy of such notice has been received by the Company from the
Trustee. Any Global Note exchanged pursuant to Clause (A) above shall be so exchanged in whole and not in part and any Global Note exchanged pursuant to Clause (B) or (C) above may be exchanged in whole or from time to time in part as
directed by the Depositary. Any Note issued in exchange for a Global Note or any portion thereof shall be a Global Note; provided that any such Note so issued that is registered in the name of a Person other than the Depositary or a nominee
thereof shall not be a Global Note.” 
 (b) Section 304(5) of the Base Indenture is hereby amended and restated with
respect to the Notes as follows: 
 “(5) None of the Depositary or any members of, or participants in, the
Depositary (“Agent Members”), or any Person on whose behalf Agent Members may act, shall have any rights under this Indenture with respect to any Global Note, or under any Global Note, and the Depositary or such nominee, as the case may
be, may be treated by the Company, the Trustee and any agent of the Company or the Trustee as the absolute owner and holder of such Global Note for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Company, the
Trustee or any agent of the Company or the Trustee from giving effect to any written certification, proxy or other authorization furnished by the Depositary or such nominee, as the case may be, or impair, as between the Depositary, its Agent Members
and any other person on whose behalf an Agent Member may act, the operation of customary practices of such Persons governing the exercise of the rights of a holder of any Note.” 

Section 207. Maintenance of Office or Agency 

(a) With respect to any Notes that are not in the form of a Global Note, the Company shall maintain in the Borough of Manhattan, The City
of New York, New York and in London, United Kingdom an office or agency, in each case, in accordance with Section 1002 of the Base Indenture. 

(b) If and for so long as the Notes are admitted to listing on the Official List of the Luxembourg Stock Exchange and trading on the Euro
MTF, the Company shall maintain pursuant to Section 1002 of the Base Indenture an office or agency in Luxembourg where the Notes may be presented or surrendered for payment, where the Notes may be surrendered for registration of transfer or
exchange and where notices and demands to or upon the Company in respect of the Notes and the Indenture may be served. The Company has initially appointed The Bank of New York Mellon (Luxembourg) S.A. as the Paying Agent and the Transfer Agent for
such transfers and exchanges and for such notices and demands in Luxembourg with respect to the Notes. The Bank of New York Mellon (Luxembourg) S.A. has its main offices at 2-4 rue Eugène Rupert, Vertigo Building-Polaris, L-2453 Luxembourg.

 (c) If for any reason The Bank of New York Mellon (Luxembourg) S.A. shall not continue as the Luxembourg Paying Agent or
Luxembourg Transfer Agent for such transfers and exchanges and for such notices and demands in Luxembourg with respect to the Notes and the Notes are admitted to 

 

 15 

 
listing on the Official List of the Luxembourg Stock Exchange and trading on the Euro MTF, the Company shall appoint a substitute Paying Agent or Transfer Agent in Luxembourg, in accordance with
the rules then in effect of the Luxembourg Stock Exchange and the provisions of the Indenture and the Notes. Following the appointment of a substitute Paying Agent or Transfer Agent in Luxembourg, the Company shall give the Holders of the Notes
notice of such appointment pursuant to Section 106 of the Base Indenture. 
 Section 208. Euro MTF Listing 

The Company shall use its reasonable best efforts to have the Notes admitted to listing on the Official List of the Luxembourg Stock
Exchange and trading on the Euro MTF; provided, however, that the Company will not be required to maintain such admission to listing and trading. 

Section 209. Additional Amounts 

For purposes of Section 1009 of the Base Indenture and for the avoidance of doubt, no Additional Amounts will be payable to any
Holder with respect to any non-Mexican Taxes, including any taxes withheld on a Note pursuant to the European Union Savings Directive or any law implementing or complying with, or introduced in order to conform to the European Union Savings
Directive. 
 ARTICLE THREE 

MISCELLANEOUS PROVISIONS 

Section 301. Consent to Service; Jurisdiction 

Each party hereto agrees that any legal suit, action or proceeding arising out of or relating to this Fifth Supplemental Indenture, the
Base Indenture, the Notes or the Guarantees may be instituted in any federal or state court in the Borough of Manhattan, The City of New York, New York and in the courts of its own corporate domicile, in respect of actions brought against each such
party as a defendant, and each waives any objection which it may now or hereafter have to the laying of the venue of any such legal suit, action or proceeding, waives any immunity from jurisdiction or to service of process in respect of any such
suit, action or proceeding, waives any right to which it may be entitled on account of place of residence or domicile, and irrevocably submits to the jurisdiction of any such court in any such suit, action or proceeding. Each of the Company and the
Guarantor hereby designates and appoints CT Corporation System, 111 Eighth Avenue, 13th Floor, New York, New York 10011, as its authorized agent upon which process may be served in any legal suit, action or proceeding arising out of or relating to
this Fifth Supplemental Indenture, the Notes or the Guarantees which may be instituted in any federal or state court in the Borough of Manhattan, The City of New York, New York, and agrees that service of process upon such agent shall be deemed in
every respect effective service of process upon the Company in any such suit, action or proceeding and further designates its domicile, the domicile of CT Corporation System specified above and any domicile CT Corporation System may have in the
future as its domicile to receive any notice hereunder (including service of process). If for any reason CT Corporation System (or any successor agent for this purpose) shall cease to act as agent for service of process as provided above, each of
the Company and the Guarantor will promptly appoint a successor agent for this purpose reasonably acceptable to the Trustee. Each of the Company and the Guarantor agrees to take any and all actions as may be necessary to maintain such designation
and appointment of such agent in full force and effect. 
  

 16 

 Section 302. Indemnification of Judgment Currency 

The Company and the Guarantor shall indemnify the Trustee and any Holder of a Note against any loss incurred by the Trustee or such
Holder, as the case may be, as a result of any judgment or order being given or made for any amount due under the Indenture or such Note and being expressed and paid in a currency (the “Judgment Currency”) other than euro, and as a result
of any variation between (i) the rate of exchange at which the euro amount is converted into the Judgment Currency for the purpose of such judgment or order and (ii) the spot rate of exchange in Frankfurt, Germany at which the Trustee or
such Holder, as the case may be, on the date of payment of such judgment or order is able to purchase euro with the amount of the Judgment Currency actually received by the Trustee or such Holder. Notwithstanding the preceding sentence of this
Section 302, in the event that the amount of euro purchased by any Holder as a result of such indemnification exceeds the amount originally to be paid to such Holder, such Holder shall reimburse such excess to the Company or the Guarantor, as
the case may be. The foregoing indemnity shall constitute a separate and independent obligation of the Company and the Guarantor and shall continue in full force and effect notwithstanding any such judgment or order as aforesaid. The term “spot
rate of exchange” shall include any premiums and costs of exchange payable in connection with the purchase of, or conversion into, euro. 

Section 303. Governing Law; Waiver of Jury Trial 

(a) THIS FIFTH SUPPLEMENTAL INDENTURE, THE NOTES AND THE GUARANTEES SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF
THE STATE OF NEW YORK. 
 (b) EACH OF THE PARTIES HERETO (EXCEPT, FOR THE AVOIDANCE OF DOUBT, THE HOLDERS OF THE NOTES)
HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ALL RIGHTS TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THE BASE INDENTURE, THIS FIFTH
SUPPLEMENTAL INDENTURE, THE NOTES, THE GUARANTEES OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. 
 Section 304. Separability of Invalid
Provisions 
 In case any one or more of the provisions contained in this Fifth Supplemental Indenture should be invalid,
illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions contained in this Fifth Supplemental Indenture, and to the extent and only to the extent that any such provision is
invalid, illegal or unenforceable, this Fifth Supplemental Indenture shall be construed as if such provision had never been contained herein. 

Section 305. Execution in Counterparts 

This Fifth Supplemental Indenture may be simultaneously executed and delivered in any number of counterparts, each of which when so
executed and delivered shall be deemed to be an original, and such counterparts shall together constitute but one and the same instrument. 
  

 17 

 Section 306. Certain Matters 

The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Fifth Supplemental
Indenture or for or in respect of the recitals contained herein, all of which are made solely by the Company and the Guarantor. 

[Signature page follows] 
  

 18 

 IN WITNESS WHEREOF, the parties hereto have caused this Fifth Supplemental Indenture to be
duly executed on their respective behalves, all as of the day and year first written above. 
  

					
	AMÉRICA MÓVIL, S.A.B. DE C.V.,
	        as Issuer
		
	By:	 	            /s/ Daniel Hajj Aboumrad
		 	Name:	 	Daniel Hajj Aboumrad
		 	Title:	 	Chief Executive Officer
		
	By:	 	            /s/ Alejandro Cantú
Jiménez
		 	Name:	 	Alejandro Cantú Jiménez
		 	Title:	 	General Counsel
	  
 RADIOMÓVIL DIPSA, S.A. DE C.V.,

        as Guarantor

		
	By:	 	            /s/ Daniel Hajj Aboumrad
		 	Name:	 	Daniel Hajj Aboumrad
		 	Title:	 	Attorney-in-Fact
		
	By:	 	            /s/ Alejandro Cantú
Jiménez
		 	Name:	 	Alejandro Cantú Jiménez
		 	Title:	 	General Counsel

  

 19 

					
	THE BANK OF NEW YORK MELLON,
	         as Trustee, Security Registrar, Paying Agent and

        Transfer Agent

		
	By:	 	            /s/ Karen Ferry
		 	Name:	 	Karen Ferry
		 	Title:	 	Vice President
	
	THE BANK OF NEW YORK MELLON (LUXEMBOURG) S.A., as Luxembourg Paying Agent and Luxembourg Transfer Agent
		
	By:	 	            /s/ Karen Ferry
		 	Name:	 	Karen Ferry
		 	Title:	 	Attorney-in-Fact

  

 20

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00175-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00175-of-00352.parquet"}]]